Poolbeg Pharma "really open" to different types of deal for POLB 001

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) VP of Business Development David English speaks to Proactive's Thomas Warner about the work he's doing to progress the clinical stage infectious disease pharmaceutical company's lead asset POLB 001.

English says that Poolbeg is "in a good position" for partnering in general, adding that the company is "really open" to different types of deals for lead asset POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.28
+5.59 (2.53%)
AAPL  275.92
+4.43 (1.63%)
AMD  215.05
+11.27 (5.53%)
BAC  51.93
+0.37 (0.72%)
GOOG  318.47
+18.82 (6.28%)
META  613.05
+18.80 (3.16%)
MSFT  474.00
+1.88 (0.40%)
NVDA  182.55
+3.67 (2.05%)
ORCL  200.28
+1.52 (0.76%)
TSLA  417.78
+26.69 (6.82%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.